DiaMedica Therapeutics (DMAC) Assets (2017 - 2026)

DiaMedica Therapeutics has reported Assets for 10 years, with the latest figure at $53.1 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 36.7% year-over-year to $53.1 million; the trailing twelve-month figure through Mar 2026 stood at $53.1 million (up 36.7% YoY), and the FY2025 full-year result was $61.4 million, up 32.42% from the prior year.
• Assets for Q1 2026 stood at $53.1 million, down from $61.4 million in the prior quarter.
• The five-year high for Assets was $62.0 million in Q2 2023, with the low at $30.2 million in Q1 2023.
• Historically, Assets has averaged $47.3 million across 5 years, with a median of $49.3 million in 2024.
• Annual changes were most pronounced in 2022 — Assets soared 80.3% — and 2025, when it tumbled 44.59%.
• DiaMedica Therapeutics' Assets stood at $34.4 million in 2022, then jumped by 57.46% to $54.2 million in 2023, then dropped by 14.43% to $46.3 million in 2024, then surged by 32.42% to $61.4 million in 2025, then declined by 13.51% to $53.1 million in 2026.
• The last three Assets figures came in at $53.1 million (Q1 2026), $61.4 million (Q4 2025), and $57.0 million (Q3 2025), per Business Quant data.